Dr. Johnathan Zhang, MD
NPI: 1346532132
Total Payments
$9,771
2024 Payments
$1,713
Companies
31
Transactions
362
Medicare Patients
2,603
Medicare Billing
$281,151
Payment Breakdown by Category
Food & Beverage$9,104 (93.2%)
Travel$562.93 (5.8%)
Education$104.12 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,104 | 358 | 93.2% |
| Travel and Lodging | $562.93 | 2 | 5.8% |
| Education | $104.12 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,318 | 93 | $0 (2024) |
| Gilead Sciences, Inc. | $1,388 | 42 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,225 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $838.93 | 41 | $0 (2024) |
| Boston Scientific Corporation | $785.43 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $589.47 | 34 | $0 (2024) |
| GENZYME CORPORATION | $563.02 | 14 | $0 (2024) |
| Madrigal Pharmaceuticals | $185.73 | 3 | $0 (2024) |
| Allergan, Inc. | $183.33 | 6 | $0 (2020) |
| Daiichi Sankyo Inc. | $175.96 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,713 | 60 | ABBVIE INC. ($237.85) |
| 2023 | $2,069 | 47 | Boston Scientific Corporation ($613.27) |
| 2022 | $1,405 | 59 | ABBVIE INC. ($334.92) |
| 2021 | $1,052 | 70 | AbbVie Inc. ($464.20) |
| 2020 | $623.95 | 31 | Gilead Sciences, Inc. ($196.37) |
| 2019 | $1,435 | 58 | Takeda Pharmaceuticals U.S.A., Inc. ($310.92) |
| 2018 | $812.85 | 25 | AbbVie, Inc. ($189.71) |
| 2017 | $661.06 | 12 | Gilead Sciences Inc ($262.51) |
All Payment Transactions
362 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.42 | General |
| 12/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: LIVER DISEASE | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $131.33 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 09/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | Cash or cash equivalent | $122.31 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $9.65 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.33 | General |
| 08/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Gastroenterology | ||||||
| 08/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 536 | 563 | $719,587 | $59,781 |
| 2022 | 14 | 709 | 767 | $860,381 | $77,536 |
| 2021 | 13 | 732 | 794 | $847,848 | $79,187 |
| 2020 | 13 | 626 | 709 | $604,146 | $64,647 |
Total Patients
2,603
Total Services
2,833
Medicare Billing
$281,151
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 93 | 95 | $203,215 | $18,733 | 9.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 57 | $40,193 | $7,356 | 18.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 68 | $36,040 | $7,347 | 20.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 91 | 102 | $135,252 | $6,966 | 5.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 112 | 112 | $204,972 | $5,624 | 2.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 48 | $24,735 | $4,877 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $27,540 | $4,122 | 15.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $13,146 | $2,454 | 18.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 14 | 15 | $31,170 | $1,446 | 4.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 13 | $3,324 | $856.05 | 25.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 117 | 119 | $258,104 | $23,801 | 9.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 72 | 92 | $43,868 | $12,750 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 62 | 62 | $36,454 | $8,120 | 22.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 93 | 97 | $128,887 | $5,738 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 58 | $21,460 | $5,684 | 26.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 48 | $25,440 | $5,328 | 20.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 126 | 128 | $236,976 | $4,500 | 1.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $18,187 | $4,399 | 24.2% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 15 | $26,115 | $2,217 | 8.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 27 | 37 | $8,880 | $2,170 | 24.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 15 | $31,170 | $1,295 | 4.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 16 | $4,192 | $1,062 | 25.3% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2022 | 13 | 16 | $8,992 | $311.76 | 3.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 36 | 37 | $11,655 | $161.48 | 1.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 101 | 102 | $218,718 | $20,187 | 9.2% |
About Dr. Johnathan Zhang, MD
Dr. Johnathan Zhang, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2011. The National Provider Identifier (NPI) number assigned to this provider is 1346532132.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johnathan Zhang, MD has received a total of $9,771 in payments from pharmaceutical and medical device companies, with $1,713 received in 2024. These payments were reported across 362 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,104).
As a Medicare-enrolled provider, Zhang has provided services to 2,603 Medicare beneficiaries, totaling 2,833 services with total Medicare billing of $281,151. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Gastroenterology
- Location Sacramento, CA
- Active Since 05/11/2011
- Last Updated 08/29/2017
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346532132
Products in Payments
- ENTYVIO (Biological) $712.50
- STELARA (Biological) $689.52
- DUPIXENT (Biological) $604.86
- RINVOQ (Biological) $598.58
- HUMIRA (Biological) $583.49
- XIFAXAN (Drug) $435.85
- Vemlidy (Drug) $417.23
- Epclusa (Drug) $368.44
- TRULANCE (Drug) $361.92
- LINZESS (Drug) $312.86
- SKYRIZI (Biological) $234.29
- RESMETIROM (Drug) $185.73
- Entyvio (Biological) $176.20
- INJECTAFER (Drug) $175.96
- Humira (Biological) $169.25
- Mulpleta (Drug) $166.44
- COOK MEDICAL HEMOSTASIS (Device) $136.06
- Motegrity (Drug) $134.72
- MONOVISC (Device) $129.86
- Viekira (Drug) $123.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Sacramento
Dr. Sarju Patel, M.d. Msc, M.D. MSC
Student in an Organized Health Care Education/Training Program — Payments: $138,721
Student in an Organized Health Care Education/Training Program $138,721
Dr. Aaron Schelegle, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $94,209
Student in an Organized Health Care Education/Training Program $94,209
Karishma Chawla, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $71,495
Student in an Organized Health Care Education/Training Program $71,495
Jonathan Man, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $42,162
Student in an Organized Health Care Education/Training Program $42,162
Christopher Campos, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $39,934
Student in an Organized Health Care Education/Training Program $39,934
Brian Joves, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $29,224
Student in an Organized Health Care Education/Training Program $29,224